ImmunoPrecise Antibodies Ltd. IPA
$ 0.38
-6.86%
Annual report 2022
added 07-29-2022
Country |
Canada |
IPO year |
- |
Industry |
- |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
- |
Employees in the company |
- |
Shares |
19.7 M |
Market Cap[1] |
$ 7.48 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.